Ganglion-blocking antiadrenergic agents

Foundation children elsewhere

• XM13Z0 – Mecamylamine
• XM4BZ9 – Trimethaphan

Sibling codes

• XM00F2 – Saralasin
• XM01D4 – Raudixin
• XM0CY8 – Apresoline
• XM0YY0 – Ketanserin
• XM1AF9 – Agents affecting arteriolar smooth muscle
• XM1F18 – Metirosine
• XM1GS9 – Protoveratrine (s) (A) (B)
• XM1LN2 – Harmonyl
• XM1TT7 – DHE 45
• XM1U35 – Pargyline
• XM24X9 – Dihydrazine
• XM28Y3 – Alseroxylon
• XM2PT6 – Antihypertensive drug
• XM2W66 – Sodium nitroprusside
• XM3HS0 – Teprotide
• XM3WP0 – Antagonist serotonin
• XM48R9 – Veratrine
• XM4EP4 – Hypotensive drug
• XM4FW8 – Benazepril hydrochloride
• XM4NN7 – Alkavervir
• XM4X84 – Centrally acting antiadrenergic agents
• XM5E71 – Budralazine
• XM5ET8 – Guanacline
• XM5FH0 – Rautotal
• XM5JL6 – Guanadrel
• XM5PW7 – Rauwoldin
• XM5T36 – Todralazine
• XM6E07 – Serpasil
• XM6T97 – Amiquinsin
• XM74W2 – Rautina
• XM7HA8 – Moderil
• XM7NV2 – Guanabenz
• XM7TE8 – Guanoctine
• XM7W35 – Methyldopate
• XM8AK5 – Syrosingopine
• XM8BQ9 – Veratrum
• XM8SX7 – Peripherally acting antiadrenergic agents
• XM9W04 – Cryptenamine (tannates)

Foundation entity

Ganglion-blocking antiadrenergic agents – http://id.who.int/icd/entity/350703473